CRIBL - Contrôle de la Réponse Immune B et Lymphoproliférations

Type: Research unit evaluation report

Evaluation campaign: 2020-2022 (group B) - Published on: 15/07/2021

Institution(s) concerned: Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM , Université de Limoges

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE3 Microbiology, Virology, Immunity

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS1_1 Molecular biology and interactions ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine ; LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics

Name of unit teams: Molecular Mechanisms of B-cell Cancerogenesis (2MB2C) ; B-celll Nuclear ArchiTecture, Ig genes and ONcogenes (B-NATION) ; Biology of Plasma cell, Immunopathology and Cancer (BioPIC)